cell_suspension.biomaterial_core.HDBR_accession;cell_suspension.biomaterial_core.biomaterial_description;cell_suspension.biomaterial_core.biomaterial_id;cell_suspension.biomaterial_core.biomaterial_id_index1;cell_suspension.biomaterial_core.biomaterial_name;cell_suspension.biomaterial_core.biosamples_accession;cell_suspension.biomaterial_core.genotype;cell_suspension.biomaterial_core.insdc_sample_accession;cell_suspension.biomaterial_core.ncbi_taxon_id;cell_suspension.biomaterial_core.supplementary_files;cell_suspension.cell_morphology.cell_morphology;cell_suspension.cell_morphology.cell_size;cell_suspension.cell_morphology.cell_size_unit.ontology;cell_suspension.cell_morphology.cell_size_unit.ontology_label;cell_suspension.cell_morphology.cell_size_unit.text;cell_suspension.cell_morphology.cell_viability_method;cell_suspension.cell_morphology.cell_viability_result;cell_suspension.cell_morphology.percent_cell_viability;cell_suspension.cell_morphology.percent_necrosis;cell_suspension.estimated_cell_count;cell_suspension.genus_species.ontology;cell_suspension.genus_species.ontology_label;cell_suspension.genus_species.text;cell_suspension.growth_conditions.growth_medium;cell_suspension.growth_conditions.passage_number;cell_suspension.plate_based_sequencing.plate_label;cell_suspension.plate_based_sequencing.well_label;cell_suspension.plate_based_sequencing.well_quality;cell_suspension.selected_cell_types.ontology;cell_suspension.selected_cell_types.ontology_label;cell_suspension.selected_cell_types.text;collection_protocol.protocol_core.protocol_id;dissociation_protocol.protocol_core.protocol_id;donor_organism.biomaterial_core.HDBR_accession;donor_organism.biomaterial_core.biomaterial_description;donor_organism.biomaterial_core.biomaterial_id;donor_organism.biomaterial_core.biomaterial_name;donor_organism.biomaterial_core.biosamples_accession;donor_organism.biomaterial_core.genotype;donor_organism.biomaterial_core.insdc_sample_accession;donor_organism.biomaterial_core.ncbi_taxon_id;donor_organism.biomaterial_core.supplementary_files;donor_organism.development_stage.ontology;donor_organism.development_stage.ontology_label;donor_organism.development_stage.text;donor_organism.diseases.ontology;donor_organism.diseases.ontology_label;donor_organism.diseases.text;donor_organism.genus_species.ontology;donor_organism.genus_species.ontology_label;donor_organism.genus_species.text;donor_organism.human_specific.body_mass_index;donor_organism.human_specific.ethnicity.ontology;donor_organism.human_specific.ethnicity.ontology_label;donor_organism.human_specific.ethnicity.text;donor_organism.is_living;donor_organism.organism_age;donor_organism.organism_age_unit.ontology;donor_organism.organism_age_unit.ontology_label;donor_organism.organism_age_unit.text;donor_organism.sex;enrichment_protocol.protocol_core.protocol_id;index;library_preparation_protocol.cdna_library_amplification_method.ontology;library_preparation_protocol.cdna_library_amplification_method.ontology_label;library_preparation_protocol.cdna_library_amplification_method.text;library_preparation_protocol.cell_barcode.barcode_length;library_preparation_protocol.cell_barcode.barcode_offset;library_preparation_protocol.cell_barcode.barcode_read;library_preparation_protocol.cell_barcode.white_list_file;library_preparation_protocol.end_bias;library_preparation_protocol.input_nucleic_acid_molecule.ontology;library_preparation_protocol.input_nucleic_acid_molecule.ontology_label;library_preparation_protocol.input_nucleic_acid_molecule.text;library_preparation_protocol.library_construction_kit.catalog_number;library_preparation_protocol.library_construction_kit.expiry_date;library_preparation_protocol.library_construction_kit.kit_titer;library_preparation_protocol.library_construction_kit.lot_number;library_preparation_protocol.library_construction_kit.manufacturer;library_preparation_protocol.library_construction_kit.retail_name;library_preparation_protocol.library_construction_method.ontology;library_preparation_protocol.library_construction_method.ontology_label;library_preparation_protocol.library_construction_method.text;library_preparation_protocol.library_preamplification_method.ontology;library_preparation_protocol.library_preamplification_method.ontology_label;library_preparation_protocol.library_preamplification_method.text;library_preparation_protocol.nominal_length;library_preparation_protocol.nominal_sdev;library_preparation_protocol.nucleic_acid_conversion_kit.catalog_number;library_preparation_protocol.nucleic_acid_conversion_kit.expiry_date;library_preparation_protocol.nucleic_acid_conversion_kit.kit_titer;library_preparation_protocol.nucleic_acid_conversion_kit.lot_number;library_preparation_protocol.nucleic_acid_conversion_kit.manufacturer;library_preparation_protocol.nucleic_acid_conversion_kit.retail_name;library_preparation_protocol.nucleic_acid_source;library_preparation_protocol.primer;library_preparation_protocol.protocol_core.document;library_preparation_protocol.protocol_core.protocol_description;library_preparation_protocol.protocol_core.protocol_id;library_preparation_protocol.protocol_core.protocol_name;library_preparation_protocol.protocol_core.protocols_io_doi;library_preparation_protocol.protocol_core.publication_doi;library_preparation_protocol.spike_in_dilution;library_preparation_protocol.spike_in_kit.catalog_number;library_preparation_protocol.spike_in_kit.expiry_date;library_preparation_protocol.spike_in_kit.kit_titer;library_preparation_protocol.spike_in_kit.lot_number;library_preparation_protocol.spike_in_kit.manufacturer;library_preparation_protocol.spike_in_kit.retail_name;library_preparation_protocol.strand;library_preparation_protocol.umi_barcode.barcode_length;library_preparation_protocol.umi_barcode.barcode_offset;library_preparation_protocol.umi_barcode.barcode_read;library_preparation_protocol.umi_barcode.white_list_file;process.deviation_from_protocol_x;process.deviation_from_protocol_y;process.end_time_x;process.end_time_y;process.insdc_experiment.insdc_experiment_accession_x;process.insdc_experiment.insdc_experiment_accession_y;process.length_of_time_unit.ontology_label_x;process.length_of_time_unit.ontology_label_y;process.length_of_time_unit.ontology_x;process.length_of_time_unit.ontology_y;process.length_of_time_unit.text_x;process.length_of_time_unit.text_y;process.length_of_time_x;process.length_of_time_y;process.process_core.location_x;process.process_core.location_y;process.process_core.operators_x;process.process_core.operators_y;process.process_core.process_description;process.process_core.process_description_x;process.process_core.process_description_y;process.process_core.process_id;process.process_core.process_id_x;process.process_core.process_id_y;process.process_core.process_name;process.process_core.process_name_x;process.process_core.process_name_y;process.start_time_x;process.start_time_y;process.type.ontology_label_x;process.type.ontology_label_y;process.type.ontology_x;process.type.ontology_y;process.type.text_x;process.type.text_y;sequence_file.file_core.checksum;sequence_file.file_core.content_description.ontology;sequence_file.file_core.content_description.ontology_label;sequence_file.file_core.content_description.text;sequence_file.file_core.file_name_index1;sequence_file.file_core.file_name_read1;sequence_file.file_core.file_name_read2;sequence_file.file_core.format;sequence_file.insdc_run_accessions;sequence_file.lane_index;sequence_file.lane_index_index1;sequence_file.library_prep_id;sequence_file.read_index;sequence_file.read_length_index1;sequence_file.read_length_read1;sequence_file.read_length_read2;sequencing_protocol.10x.drop_uniformity;sequencing_protocol.10x.fastq_method;sequencing_protocol.10x.fastq_method_version;sequencing_protocol.10x.pooled_channels;sequencing_protocol.instrument_manufacturer_model.ontology;sequencing_protocol.instrument_manufacturer_model.ontology_label;sequencing_protocol.instrument_manufacturer_model.text;sequencing_protocol.local_machine_name;sequencing_protocol.method.ontology;sequencing_protocol.method.ontology_label;sequencing_protocol.method.text;sequencing_protocol.paired_end;sequencing_protocol.protocol_core.document;sequencing_protocol.protocol_core.protocol_description;sequencing_protocol.protocol_core.protocol_id;sequencing_protocol.protocol_core.protocol_name;sequencing_protocol.protocol_core.protocols_io_doi;sequencing_protocol.protocol_core.publication_doi;specimen_from_organism.biomaterial_core.HDBR_accession;specimen_from_organism.biomaterial_core.biomaterial_description;specimen_from_organism.biomaterial_core.biomaterial_id;specimen_from_organism.biomaterial_core.biomaterial_name;specimen_from_organism.biomaterial_core.biosamples_accession;specimen_from_organism.biomaterial_core.genotype;specimen_from_organism.biomaterial_core.insdc_sample_accession;specimen_from_organism.biomaterial_core.ncbi_taxon_id;specimen_from_organism.biomaterial_core.supplementary_files;specimen_from_organism.collection_time;specimen_from_organism.diseases.ontology;specimen_from_organism.diseases.ontology_label;specimen_from_organism.diseases.text;specimen_from_organism.genus_species.ontology;specimen_from_organism.genus_species.ontology_label;specimen_from_organism.genus_species.text;specimen_from_organism.organ.ontology;specimen_from_organism.organ.ontology_label;specimen_from_organism.organ.text;specimen_from_organism.organ_parts.ontology;specimen_from_organism.organ_parts.ontology_label;specimen_from_organism.organ_parts.text;dissociation_protocol.protocol_core.protocol_id_0;dissociation_protocol.protocol_core.protocol_id_count;dissociation_protocol.protocol_core.protocol_id_list;enrichment_protocol.protocol_core.protocol_id_0;enrichment_protocol.protocol_core.protocol_id_count;enrichment_protocol.protocol_core.protocol_id_list
;;GSM4577306;GSM4577306;D14-endometrium_biopsy-10x-cells;SAMN15049051;;;9606.0;;;;;;;;;;;;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;;;;;collection_protocol;dissociation_protocol;;"The donor is one of a group of healthy and fertile women aged 18-34 years with regular menstrual cycling (3-4 d every 28-30 d), body mass index 19-29 kg m-2 (inclusive), normal karyotype and negative serological tests for human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis. Women with the following conditions were excluded from tissue collection: recent contraception (intrauterine device usage in past 3 months; hormonal contraceptives in past 2 months), uterine pathology (endometriosis, leiomyoma or adenomyosis; bacterial, fungal or viral infection) or polycystic ovary syndrome.";D14;;;;;9606.0;;HsapDv:0000087;human adult stage;human adult stage;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;yes;18-34;UO:0000036;year;year;female;enrichment_protocol_1;0;;;;16.0;0.0;Read 1;;3 prime tag;OBI:0000869;polyA RNA;polyA RNA;;;;;;;EFO:0009922;10x 3' v3 sequencing;10x 3' v3 sequencing;;;;;;;;;;;;single cell;poly-dT;;GEM generation and barcoding, reverse-transcription, cDNA generation were done following the manufacturer’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics). Library construction were done following the manufacture’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics).;10x_library_protocol;Chromium 10x single-cell RNA-seq library generation.;;;;;;;;;;first;12.0;16.0;Read 1;;;;;;SRX8419321;SRX8419321;;;;;;;;;;;;;;;;;;SRX8419321;;;;;;;;;;;;;data:3494;DNA sequence;DNA sequence;endo_14_S1_L001_I1_001.fastq.gz;endo_14_S1_L001_R1_001.fastq.gz;endo_14_S1_L001_R2_001.fastq.gz;fastq.gz;SRR11869223;1.0;1.0;SRX8419321;read1;;;;;Cellranger;3.1.0;;EFO:0008637;Illumina NovaSeq 6000;Illumina NovaSeq 6000;;EFO:0008440;tag based single cell RNA sequencing;tag based single cell RNA sequencing;no;;Dual-indexed, single-cell libraries were pooled and sequenced in paired-end reads on Novaseq (Illumina).;GPL24676;Illumina NovaSeq 6000;;;;Endometrial biopsy taken 27 days after the onset of menstrual bleeding (histologically early-secretory phase).;D14-endometrium_biopsy;;;;;9606.0;;;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;UBERON:0001295;endometrium;endometrium;;;;dissociation_protocol;1;['dissociation_protocol'];enrichment_protocol_1;1;['enrichment_protocol_1']
;;GSM4577306;GSM4577306;D14-endometrium_biopsy-10x-cells;SAMN15049051;;;9606.0;;;;;;;;;;;;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;;;;;collection_protocol;dissociation_protocol;;"The donor is one of a group of healthy and fertile women aged 18-34 years with regular menstrual cycling (3-4 d every 28-30 d), body mass index 19-29 kg m-2 (inclusive), normal karyotype and negative serological tests for human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis. Women with the following conditions were excluded from tissue collection: recent contraception (intrauterine device usage in past 3 months; hormonal contraceptives in past 2 months), uterine pathology (endometriosis, leiomyoma or adenomyosis; bacterial, fungal or viral infection) or polycystic ovary syndrome.";D14;;;;;9606.0;;HsapDv:0000087;human adult stage;human adult stage;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;yes;18-34;UO:0000036;year;year;female;enrichment_protocol_1;1;;;;16.0;0.0;Read 1;;3 prime tag;OBI:0000869;polyA RNA;polyA RNA;;;;;;;EFO:0009922;10x 3' v3 sequencing;10x 3' v3 sequencing;;;;;;;;;;;;single cell;poly-dT;;GEM generation and barcoding, reverse-transcription, cDNA generation were done following the manufacturer’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics). Library construction were done following the manufacture’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics).;10x_library_protocol;Chromium 10x single-cell RNA-seq library generation.;;;;;;;;;;first;12.0;16.0;Read 1;;;;;;SRX8419321;SRX8419321;;;;;;;;;;;;;;;;;;SRX8419321;;;;;;;;;;;;;data:3494;DNA sequence;DNA sequence;endo_14_S1_L002_I1_001.fastq.gz;endo_14_S1_L002_R1_001.fastq.gz;endo_14_S1_L002_R2_001.fastq.gz;fastq.gz;SRR11869224;2.0;2.0;SRX8419321;read1;;;;;Cellranger;3.1.0;;EFO:0008637;Illumina NovaSeq 6000;Illumina NovaSeq 6000;;EFO:0008440;tag based single cell RNA sequencing;tag based single cell RNA sequencing;no;;Dual-indexed, single-cell libraries were pooled and sequenced in paired-end reads on Novaseq (Illumina).;GPL24676;Illumina NovaSeq 6000;;;;Endometrial biopsy taken 27 days after the onset of menstrual bleeding (histologically early-secretory phase).;D14-endometrium_biopsy;;;;;9606.0;;;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;UBERON:0001295;endometrium;endometrium;;;;dissociation_protocol;1;['dissociation_protocol'];enrichment_protocol_1;1;['enrichment_protocol_1']
;;GSM4577308;GSM4577308;D20-endometrium_biopsy-10x-cells;SAMN15049049;;;9606.0;;;;;;;;;;;;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;;;;;collection_protocol;dissociation_protocol;;"The donor is one of a group of healthy and fertile women aged 18-34 years with regular menstrual cycling (3-4 d every 28-30 d), body mass index 19-29 kg m-2 (inclusive), normal karyotype and negative serological tests for human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis. Women with the following conditions were excluded from tissue collection: recent contraception (intrauterine device usage in past 3 months; hormonal contraceptives in past 2 months), uterine pathology (endometriosis, leiomyoma or adenomyosis; bacterial, fungal or viral infection) or polycystic ovary syndrome.";D20;;;;;9606.0;;HsapDv:0000087;human adult stage;human adult stage;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;yes;18-34;UO:0000036;year;year;female;enrichment_protocol_1;2;;;;16.0;0.0;Read 1;;3 prime tag;OBI:0000869;polyA RNA;polyA RNA;;;;;;;EFO:0009922;10x 3' v3 sequencing;10x 3' v3 sequencing;;;;;;;;;;;;single cell;poly-dT;;GEM generation and barcoding, reverse-transcription, cDNA generation were done following the manufacturer’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics). Library construction were done following the manufacture’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics).;10x_library_protocol;Chromium 10x single-cell RNA-seq library generation.;;;;;;;;;;first;12.0;16.0;Read 1;;;;;;SRX8419323;SRX8419323;;;;;;;;;;;;;;;;;;SRX8419323;;;;;;;;;;;;;data:3494;DNA sequence;DNA sequence;endo_20_S2_L001_I1_001.fastq.gz;endo_20_S2_L001_R1_001.fastq.gz;endo_20_S2_L001_R2_001.fastq.gz;fastq.gz;SRR11869227;1.0;1.0;SRX8419323;read1;;;;;Cellranger;3.1.0;;EFO:0008637;Illumina NovaSeq 6000;Illumina NovaSeq 6000;;EFO:0008440;tag based single cell RNA sequencing;tag based single cell RNA sequencing;no;;Dual-indexed, single-cell libraries were pooled and sequenced in paired-end reads on Novaseq (Illumina).;GPL24676;Illumina NovaSeq 6000;;;;Endometrial biopsy taken 24 days after the onset of menstrual bleeding (histologically early-secretory phase).;D20-endometrium_biopsy;;;;;9606.0;;;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;UBERON:0001295;endometrium;endometrium;;;;dissociation_protocol;1;['dissociation_protocol'];enrichment_protocol_1;1;['enrichment_protocol_1']
;;GSM4577308;GSM4577308;D20-endometrium_biopsy-10x-cells;SAMN15049049;;;9606.0;;;;;;;;;;;;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;;;;;collection_protocol;dissociation_protocol;;"The donor is one of a group of healthy and fertile women aged 18-34 years with regular menstrual cycling (3-4 d every 28-30 d), body mass index 19-29 kg m-2 (inclusive), normal karyotype and negative serological tests for human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis. Women with the following conditions were excluded from tissue collection: recent contraception (intrauterine device usage in past 3 months; hormonal contraceptives in past 2 months), uterine pathology (endometriosis, leiomyoma or adenomyosis; bacterial, fungal or viral infection) or polycystic ovary syndrome.";D20;;;;;9606.0;;HsapDv:0000087;human adult stage;human adult stage;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;yes;18-34;UO:0000036;year;year;female;enrichment_protocol_1;3;;;;16.0;0.0;Read 1;;3 prime tag;OBI:0000869;polyA RNA;polyA RNA;;;;;;;EFO:0009922;10x 3' v3 sequencing;10x 3' v3 sequencing;;;;;;;;;;;;single cell;poly-dT;;GEM generation and barcoding, reverse-transcription, cDNA generation were done following the manufacturer’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics). Library construction were done following the manufacture’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics).;10x_library_protocol;Chromium 10x single-cell RNA-seq library generation.;;;;;;;;;;first;12.0;16.0;Read 1;;;;;;SRX8419323;SRX8419323;;;;;;;;;;;;;;;;;;SRX8419323;;;;;;;;;;;;;data:3494;DNA sequence;DNA sequence;endo_20_S2_L002_I1_001.fastq.gz;endo_20_S2_L002_R1_001.fastq.gz;endo_20_S2_L002_R2_001.fastq.gz;fastq.gz;SRR11869228;2.0;2.0;SRX8419323;read1;;;;;Cellranger;3.1.0;;EFO:0008637;Illumina NovaSeq 6000;Illumina NovaSeq 6000;;EFO:0008440;tag based single cell RNA sequencing;tag based single cell RNA sequencing;no;;Dual-indexed, single-cell libraries were pooled and sequenced in paired-end reads on Novaseq (Illumina).;GPL24676;Illumina NovaSeq 6000;;;;Endometrial biopsy taken 24 days after the onset of menstrual bleeding (histologically early-secretory phase).;D20-endometrium_biopsy;;;;;9606.0;;;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;UBERON:0001295;endometrium;endometrium;;;;dissociation_protocol;1;['dissociation_protocol'];enrichment_protocol_1;1;['enrichment_protocol_1']
;;GSM4577315;GSM4577315;day16-10x-endometrium_biopsy-cells;SAMN15049042;;;9606.0;;;;;;;;;;;;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;;;;;collection_protocol;dissociation_protocol;;"The donor is one of a group of healthy and fertile women aged 18-34 years with regular menstrual cycling (3-4 d every 28-30 d), body mass index 19-29 kg m-2 (inclusive), normal karyotype and negative serological tests for human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis. Women with the following conditions were excluded from tissue collection: recent contraception (intrauterine device usage in past 3 months; hormonal contraceptives in past 2 months), uterine pathology (endometriosis, leiomyoma or adenomyosis; bacterial, fungal or viral infection) or polycystic ovary syndrome.";day16-10x;;;;;9606.0;;HsapDv:0000087;human adult stage;human adult stage;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;yes;18-34;UO:0000036;year;year;female;enrichment_protocol_1;4;;;;16.0;0.0;Read 1;;3 prime tag;OBI:0000869;polyA RNA;polyA RNA;;;;;;;EFO:0009922;10x 3' v3 sequencing;10x 3' v3 sequencing;;;;;;;;;;;;single cell;poly-dT;;GEM generation and barcoding, reverse-transcription, cDNA generation were done following the manufacturer’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics). Library construction were done following the manufacture’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics).;10x_library_protocol;Chromium 10x single-cell RNA-seq library generation.;;;;;;;;;;first;12.0;16.0;Read 1;;;;;;SRX8419320;SRX8419320;;;;;;;;;;;;;;;;;;SRX8419320;;;;;;;;;;;;;data:3494;DNA sequence;DNA sequence;endo_63_S8_L002_I1_001.fastq.gz;endo_63_S8_L002_R1_001.fastq.gz;endo_63_S8_L002_R2_001.fastq.gz;fastq.gz;SRR11869240;2.0;2.0;SRX8419320;read1;;;;;Cellranger;3.1.0;;EFO:0008637;Illumina NovaSeq 6000;Illumina NovaSeq 6000;;EFO:0008440;tag based single cell RNA sequencing;tag based single cell RNA sequencing;no;;Dual-indexed, single-cell libraries were pooled and sequenced in paired-end reads on Novaseq (Illumina).;GPL24676;Illumina NovaSeq 6000;;;;Endometrial biopsy taken 16 days after the onset of menstrual bleeding.;day16-10x-endometrium_biopsy;;;;;9606.0;;;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;UBERON:0001295;endometrium;endometrium;;;;dissociation_protocol;1;['dissociation_protocol'];enrichment_protocol_1;1;['enrichment_protocol_1']
;;GSM4577311;GSM4577311;day19-10x-endometrium_biopsy-cells;SAMN15049046;;;9606.0;;;;;;;;;;;;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;;;;;collection_protocol;dissociation_protocol;;"The donor is one of a group of healthy and fertile women aged 18-34 years with regular menstrual cycling (3-4 d every 28-30 d), body mass index 19-29 kg m-2 (inclusive), normal karyotype and negative serological tests for human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis. Women with the following conditions were excluded from tissue collection: recent contraception (intrauterine device usage in past 3 months; hormonal contraceptives in past 2 months), uterine pathology (endometriosis, leiomyoma or adenomyosis; bacterial, fungal or viral infection) or polycystic ovary syndrome.";day19-10x;;;;;9606.0;;HsapDv:0000087;human adult stage;human adult stage;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;yes;18-34;UO:0000036;year;year;female;enrichment_protocol_1;5;;;;16.0;0.0;Read 1;;3 prime tag;OBI:0000869;polyA RNA;polyA RNA;;;;;;;EFO:0009922;10x 3' v3 sequencing;10x 3' v3 sequencing;;;;;;;;;;;;single cell;poly-dT;;GEM generation and barcoding, reverse-transcription, cDNA generation were done following the manufacturer’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics). Library construction were done following the manufacture’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics).;10x_library_protocol;Chromium 10x single-cell RNA-seq library generation.;;;;;;;;;;first;12.0;16.0;Read 1;;;;;;SRX8419316;SRX8419316;;;;;;;;;;;;;;;;;;SRX8419316;;;;;;;;;;;;;data:3494;DNA sequence;DNA sequence;endo_41_S3_L001_I1_001.fastq.gz;endo_41_S3_L001_R1_001.fastq.gz;endo_41_S3_L001_R2_001.fastq.gz;fastq.gz;SRR11869233;1.0;1.0;SRX8419316;read1;;;;;Cellranger;3.1.0;;EFO:0008637;Illumina NovaSeq 6000;Illumina NovaSeq 6000;;EFO:0008440;tag based single cell RNA sequencing;tag based single cell RNA sequencing;no;;Dual-indexed, single-cell libraries were pooled and sequenced in paired-end reads on Novaseq (Illumina).;GPL24676;Illumina NovaSeq 6000;;;;Endometrial biopsy taken 19 days after the onset of menstrual bleeding.;day19-10x-endometrium_biopsy;;;;;9606.0;;;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;UBERON:0001295;endometrium;endometrium;;;;dissociation_protocol;1;['dissociation_protocol'];enrichment_protocol_1;1;['enrichment_protocol_1']
;;GSM4577311;GSM4577311;day19-10x-endometrium_biopsy-cells;SAMN15049046;;;9606.0;;;;;;;;;;;;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;;;;;collection_protocol;dissociation_protocol;;"The donor is one of a group of healthy and fertile women aged 18-34 years with regular menstrual cycling (3-4 d every 28-30 d), body mass index 19-29 kg m-2 (inclusive), normal karyotype and negative serological tests for human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis. Women with the following conditions were excluded from tissue collection: recent contraception (intrauterine device usage in past 3 months; hormonal contraceptives in past 2 months), uterine pathology (endometriosis, leiomyoma or adenomyosis; bacterial, fungal or viral infection) or polycystic ovary syndrome.";day19-10x;;;;;9606.0;;HsapDv:0000087;human adult stage;human adult stage;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;yes;18-34;UO:0000036;year;year;female;enrichment_protocol_1;6;;;;16.0;0.0;Read 1;;3 prime tag;OBI:0000869;polyA RNA;polyA RNA;;;;;;;EFO:0009922;10x 3' v3 sequencing;10x 3' v3 sequencing;;;;;;;;;;;;single cell;poly-dT;;GEM generation and barcoding, reverse-transcription, cDNA generation were done following the manufacturer’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics). Library construction were done following the manufacture’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics).;10x_library_protocol;Chromium 10x single-cell RNA-seq library generation.;;;;;;;;;;first;12.0;16.0;Read 1;;;;;;SRX8419316;SRX8419316;;;;;;;;;;;;;;;;;;SRX8419316;;;;;;;;;;;;;data:3494;DNA sequence;DNA sequence;endo_41_S3_L002_I1_001.fastq.gz;endo_41_S3_L002_R1_001.fastq.gz;endo_41_S3_L002_R2_001.fastq.gz;fastq.gz;SRR11869234;2.0;2.0;SRX8419316;read1;;;;;Cellranger;3.1.0;;EFO:0008637;Illumina NovaSeq 6000;Illumina NovaSeq 6000;;EFO:0008440;tag based single cell RNA sequencing;tag based single cell RNA sequencing;no;;Dual-indexed, single-cell libraries were pooled and sequenced in paired-end reads on Novaseq (Illumina).;GPL24676;Illumina NovaSeq 6000;;;;Endometrial biopsy taken 19 days after the onset of menstrual bleeding.;day19-10x-endometrium_biopsy;;;;;9606.0;;;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;UBERON:0001295;endometrium;endometrium;;;;dissociation_protocol;1;['dissociation_protocol'];enrichment_protocol_1;1;['enrichment_protocol_1']
;;GSM4577309;GSM4577309;day20-early-mid-secretory-10x-endometrium_biopsy-cells;SAMN15049048;;;9606.0;;;;;;;;;;;;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;;;;;collection_protocol;dissociation_protocol;;"The donor is one of a group of healthy and fertile women aged 18-34 years with regular menstrual cycling (3-4 d every 28-30 d), body mass index 19-29 kg m-2 (inclusive), normal karyotype and negative serological tests for human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis. Women with the following conditions were excluded from tissue collection: recent contraception (intrauterine device usage in past 3 months; hormonal contraceptives in past 2 months), uterine pathology (endometriosis, leiomyoma or adenomyosis; bacterial, fungal or viral infection) or polycystic ovary syndrome.";day20-early-mid-secretory-10x;;;;;9606.0;;HsapDv:0000087;human adult stage;human adult stage;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;yes;18-34;UO:0000036;year;year;female;enrichment_protocol_1;7;;;;16.0;0.0;Read 1;;3 prime tag;OBI:0000869;polyA RNA;polyA RNA;;;;;;;EFO:0009922;10x 3' v3 sequencing;10x 3' v3 sequencing;;;;;;;;;;;;single cell;poly-dT;;GEM generation and barcoding, reverse-transcription, cDNA generation were done following the manufacturer’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics). Library construction were done following the manufacture’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics).;10x_library_protocol;Chromium 10x single-cell RNA-seq library generation.;;;;;;;;;;first;12.0;16.0;Read 1;;;;;;SRX8419314;SRX8419314;;;;;;;;;;;;;;;;;;SRX8419314;;;;;;;;;;;;;data:3494;DNA sequence;DNA sequence;endo_29_S7_L001_I1_001.fastq.gz;endo_29_S7_L001_R1_001.fastq.gz;endo_29_S7_L001_R2_001.fastq.gz;fastq.gz;SRR11869229;1.0;1.0;SRX8419314;read1;;;;;Cellranger;3.1.0;;EFO:0008637;Illumina NovaSeq 6000;Illumina NovaSeq 6000;;EFO:0008440;tag based single cell RNA sequencing;tag based single cell RNA sequencing;no;;Dual-indexed, single-cell libraries were pooled and sequenced in paired-end reads on Novaseq (Illumina).;GPL24676;Illumina NovaSeq 6000;;;;Endometrial biopsy taken 20 days after the onset of menstrual bleeding.;day20-early-mid-secretory-10x-endometrium_biopsy;;;;;9606.0;;;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;UBERON:0001295;endometrium;endometrium;;;;dissociation_protocol;1;['dissociation_protocol'];enrichment_protocol_1;1;['enrichment_protocol_1']
;;GSM4577309;GSM4577309;day20-early-mid-secretory-10x-endometrium_biopsy-cells;SAMN15049048;;;9606.0;;;;;;;;;;;;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;;;;;collection_protocol;dissociation_protocol;;"The donor is one of a group of healthy and fertile women aged 18-34 years with regular menstrual cycling (3-4 d every 28-30 d), body mass index 19-29 kg m-2 (inclusive), normal karyotype and negative serological tests for human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis. Women with the following conditions were excluded from tissue collection: recent contraception (intrauterine device usage in past 3 months; hormonal contraceptives in past 2 months), uterine pathology (endometriosis, leiomyoma or adenomyosis; bacterial, fungal or viral infection) or polycystic ovary syndrome.";day20-early-mid-secretory-10x;;;;;9606.0;;HsapDv:0000087;human adult stage;human adult stage;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;yes;18-34;UO:0000036;year;year;female;enrichment_protocol_1;8;;;;16.0;0.0;Read 1;;3 prime tag;OBI:0000869;polyA RNA;polyA RNA;;;;;;;EFO:0009922;10x 3' v3 sequencing;10x 3' v3 sequencing;;;;;;;;;;;;single cell;poly-dT;;GEM generation and barcoding, reverse-transcription, cDNA generation were done following the manufacturer’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics). Library construction were done following the manufacture’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics).;10x_library_protocol;Chromium 10x single-cell RNA-seq library generation.;;;;;;;;;;first;12.0;16.0;Read 1;;;;;;SRX8419314;SRX8419314;;;;;;;;;;;;;;;;;;SRX8419314;;;;;;;;;;;;;data:3494;DNA sequence;DNA sequence;endo_29_S7_L002_I1_001.fastq.gz;endo_29_S7_L002_R1_001.fastq.gz;endo_29_S7_L002_R2_001.fastq.gz;fastq.gz;SRR11869230;2.0;2.0;SRX8419314;read1;;;;;Cellranger;3.1.0;;EFO:0008637;Illumina NovaSeq 6000;Illumina NovaSeq 6000;;EFO:0008440;tag based single cell RNA sequencing;tag based single cell RNA sequencing;no;;Dual-indexed, single-cell libraries were pooled and sequenced in paired-end reads on Novaseq (Illumina).;GPL24676;Illumina NovaSeq 6000;;;;Endometrial biopsy taken 20 days after the onset of menstrual bleeding.;day20-early-mid-secretory-10x-endometrium_biopsy;;;;;9606.0;;;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;UBERON:0001295;endometrium;endometrium;;;;dissociation_protocol;1;['dissociation_protocol'];enrichment_protocol_1;1;['enrichment_protocol_1']
;;GSM4577313;GSM4577313;day20-early-secretory-10x-endometrium_biopsy-cells;SAMN15049044;;;9606.0;;;;;;;;;;;;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;;;;;collection_protocol;dissociation_protocol;;"The donor is one of a group of healthy and fertile women aged 18-34 years with regular menstrual cycling (3-4 d every 28-30 d), body mass index 19-29 kg m-2 (inclusive), normal karyotype and negative serological tests for human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis. Women with the following conditions were excluded from tissue collection: recent contraception (intrauterine device usage in past 3 months; hormonal contraceptives in past 2 months), uterine pathology (endometriosis, leiomyoma or adenomyosis; bacterial, fungal or viral infection) or polycystic ovary syndrome.";day20-early-secretory-10x;;;;;9606.0;;HsapDv:0000087;human adult stage;human adult stage;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;yes;18-34;UO:0000036;year;year;female;enrichment_protocol_1;9;;;;16.0;0.0;Read 1;;3 prime tag;OBI:0000869;polyA RNA;polyA RNA;;;;;;;EFO:0009922;10x 3' v3 sequencing;10x 3' v3 sequencing;;;;;;;;;;;;single cell;poly-dT;;GEM generation and barcoding, reverse-transcription, cDNA generation were done following the manufacturer’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics). Library construction were done following the manufacture’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics).;10x_library_protocol;Chromium 10x single-cell RNA-seq library generation.;;;;;;;;;;first;12.0;16.0;Read 1;;;;;;SRX8419318;SRX8419318;;;;;;;;;;;;;;;;;;SRX8419318;;;;;;;;;;;;;data:3494;DNA sequence;DNA sequence;endo_58_S4_L001_I1_001.fastq.gz;endo_58_S4_L001_R1_001.fastq.gz;endo_58_S4_L001_R2_001.fastq.gz;fastq.gz;SRR11869236;1.0;1.0;SRX8419318;read1;;;;;Cellranger;3.1.0;;EFO:0008637;Illumina NovaSeq 6000;Illumina NovaSeq 6000;;EFO:0008440;tag based single cell RNA sequencing;tag based single cell RNA sequencing;no;;Dual-indexed, single-cell libraries were pooled and sequenced in paired-end reads on Novaseq (Illumina).;GPL24676;Illumina NovaSeq 6000;;;;Endometrial biopsy taken 20 days after the onset of menstrual bleeding.;day20-early-secretory-10x-endometrium_biopsy;;;;;9606.0;;;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;UBERON:0001295;endometrium;endometrium;;;;dissociation_protocol;1;['dissociation_protocol'];enrichment_protocol_1;1;['enrichment_protocol_1']
;;GSM4577313;GSM4577313;day20-early-secretory-10x-endometrium_biopsy-cells;SAMN15049044;;;9606.0;;;;;;;;;;;;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;;;;;collection_protocol;dissociation_protocol;;"The donor is one of a group of healthy and fertile women aged 18-34 years with regular menstrual cycling (3-4 d every 28-30 d), body mass index 19-29 kg m-2 (inclusive), normal karyotype and negative serological tests for human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis. Women with the following conditions were excluded from tissue collection: recent contraception (intrauterine device usage in past 3 months; hormonal contraceptives in past 2 months), uterine pathology (endometriosis, leiomyoma or adenomyosis; bacterial, fungal or viral infection) or polycystic ovary syndrome.";day20-early-secretory-10x;;;;;9606.0;;HsapDv:0000087;human adult stage;human adult stage;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;yes;18-34;UO:0000036;year;year;female;enrichment_protocol_1;10;;;;16.0;0.0;Read 1;;3 prime tag;OBI:0000869;polyA RNA;polyA RNA;;;;;;;EFO:0009922;10x 3' v3 sequencing;10x 3' v3 sequencing;;;;;;;;;;;;single cell;poly-dT;;GEM generation and barcoding, reverse-transcription, cDNA generation were done following the manufacturer’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics). Library construction were done following the manufacture’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics).;10x_library_protocol;Chromium 10x single-cell RNA-seq library generation.;;;;;;;;;;first;12.0;16.0;Read 1;;;;;;SRX8419318;SRX8419318;;;;;;;;;;;;;;;;;;SRX8419318;;;;;;;;;;;;;data:3494;DNA sequence;DNA sequence;endo_58_S4_L002_I1_001.fastq.gz;endo_58_S4_L002_R1_001.fastq.gz;endo_58_S4_L002_R2_001.fastq.gz;fastq.gz;SRR11869237;2.0;2.0;SRX8419318;read1;;;;;Cellranger;3.1.0;;EFO:0008637;Illumina NovaSeq 6000;Illumina NovaSeq 6000;;EFO:0008440;tag based single cell RNA sequencing;tag based single cell RNA sequencing;no;;Dual-indexed, single-cell libraries were pooled and sequenced in paired-end reads on Novaseq (Illumina).;GPL24676;Illumina NovaSeq 6000;;;;Endometrial biopsy taken 20 days after the onset of menstrual bleeding.;day20-early-secretory-10x-endometrium_biopsy;;;;;9606.0;;;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;UBERON:0001295;endometrium;endometrium;;;;dissociation_protocol;1;['dissociation_protocol'];enrichment_protocol_1;1;['enrichment_protocol_1']
;;GSM4577307;GSM4577307;day22-proliferative-10x-endometrium_biopsy-cells;SAMN15049050;;;9606.0;;;;;;;;;;;;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;;;;;collection_protocol;dissociation_protocol;;"The donor is one of a group of healthy and fertile women aged 18-34 years with regular menstrual cycling (3-4 d every 28-30 d), body mass index 19-29 kg m-2 (inclusive), normal karyotype and negative serological tests for human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis. Women with the following conditions were excluded from tissue collection: recent contraception (intrauterine device usage in past 3 months; hormonal contraceptives in past 2 months), uterine pathology (endometriosis, leiomyoma or adenomyosis; bacterial, fungal or viral infection) or polycystic ovary syndrome.";day22-proliferative-10x;;;;;9606.0;;HsapDv:0000087;human adult stage;human adult stage;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;yes;18-34;UO:0000036;year;year;female;enrichment_protocol_1;11;;;;16.0;0.0;Read 1;;3 prime tag;OBI:0000869;polyA RNA;polyA RNA;;;;;;;EFO:0009922;10x 3' v3 sequencing;10x 3' v3 sequencing;;;;;;;;;;;;single cell;poly-dT;;GEM generation and barcoding, reverse-transcription, cDNA generation were done following the manufacturer’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics). Library construction were done following the manufacture’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics).;10x_library_protocol;Chromium 10x single-cell RNA-seq library generation.;;;;;;;;;;first;12.0;16.0;Read 1;;;;;;SRX8419322;SRX8419322;;;;;;;;;;;;;;;;;;SRX8419322;;;;;;;;;;;;;data:3494;DNA sequence;DNA sequence;endo_19_S6_L001_I1_001.fastq.gz;endo_19_S6_L001_R1_001.fastq.gz;endo_19_S6_L001_R2_001.fastq.gz;fastq.gz;SRR11869225;1.0;1.0;SRX8419322;read1;;;;;Cellranger;3.1.0;;EFO:0008637;Illumina NovaSeq 6000;Illumina NovaSeq 6000;;EFO:0008440;tag based single cell RNA sequencing;tag based single cell RNA sequencing;no;;Dual-indexed, single-cell libraries were pooled and sequenced in paired-end reads on Novaseq (Illumina).;GPL24676;Illumina NovaSeq 6000;;;;Endometrial biopsy taken 22 days after the onset of menstrual bleeding.;day22-proliferative-10x-endometrium_biopsy;;;;;9606.0;;;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;UBERON:0001295;endometrium;endometrium;;;;dissociation_protocol;1;['dissociation_protocol'];enrichment_protocol_1;1;['enrichment_protocol_1']
;;GSM4577307;GSM4577307;day22-proliferative-10x-endometrium_biopsy-cells;SAMN15049050;;;9606.0;;;;;;;;;;;;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;;;;;collection_protocol;dissociation_protocol;;"The donor is one of a group of healthy and fertile women aged 18-34 years with regular menstrual cycling (3-4 d every 28-30 d), body mass index 19-29 kg m-2 (inclusive), normal karyotype and negative serological tests for human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis. Women with the following conditions were excluded from tissue collection: recent contraception (intrauterine device usage in past 3 months; hormonal contraceptives in past 2 months), uterine pathology (endometriosis, leiomyoma or adenomyosis; bacterial, fungal or viral infection) or polycystic ovary syndrome.";day22-proliferative-10x;;;;;9606.0;;HsapDv:0000087;human adult stage;human adult stage;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;yes;18-34;UO:0000036;year;year;female;enrichment_protocol_1;12;;;;16.0;0.0;Read 1;;3 prime tag;OBI:0000869;polyA RNA;polyA RNA;;;;;;;EFO:0009922;10x 3' v3 sequencing;10x 3' v3 sequencing;;;;;;;;;;;;single cell;poly-dT;;GEM generation and barcoding, reverse-transcription, cDNA generation were done following the manufacturer’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics). Library construction were done following the manufacture’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics).;10x_library_protocol;Chromium 10x single-cell RNA-seq library generation.;;;;;;;;;;first;12.0;16.0;Read 1;;;;;;SRX8419322;SRX8419322;;;;;;;;;;;;;;;;;;SRX8419322;;;;;;;;;;;;;data:3494;DNA sequence;DNA sequence;endo_19_S6_L002_I1_001.fastq.gz;endo_19_S6_L002_R1_001.fastq.gz;endo_19_S6_L002_R2_001.fastq.gz;fastq.gz;SRR11869226;2.0;2.0;SRX8419322;read1;;;;;Cellranger;3.1.0;;EFO:0008637;Illumina NovaSeq 6000;Illumina NovaSeq 6000;;EFO:0008440;tag based single cell RNA sequencing;tag based single cell RNA sequencing;no;;Dual-indexed, single-cell libraries were pooled and sequenced in paired-end reads on Novaseq (Illumina).;GPL24676;Illumina NovaSeq 6000;;;;Endometrial biopsy taken 22 days after the onset of menstrual bleeding.;day22-proliferative-10x-endometrium_biopsy;;;;;9606.0;;;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;UBERON:0001295;endometrium;endometrium;;;;dissociation_protocol;1;['dissociation_protocol'];enrichment_protocol_1;1;['enrichment_protocol_1']
;;GSM4577310;GSM4577310;day23-10x-endometrium_biopsy-cells;SAMN15049047;;;9606.0;;;;;;;;;;;;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;;;;;collection_protocol;dissociation_protocol;;"The donor is one of a group of healthy and fertile women aged 18-34 years with regular menstrual cycling (3-4 d every 28-30 d), body mass index 19-29 kg m-2 (inclusive), normal karyotype and negative serological tests for human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis. Women with the following conditions were excluded from tissue collection: recent contraception (intrauterine device usage in past 3 months; hormonal contraceptives in past 2 months), uterine pathology (endometriosis, leiomyoma or adenomyosis; bacterial, fungal or viral infection) or polycystic ovary syndrome.";day23-10x;;;;;9606.0;;HsapDv:0000087;human adult stage;human adult stage;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;yes;18-34;UO:0000036;year;year;female;enrichment_protocol_1;13;;;;16.0;0.0;Read 1;;3 prime tag;OBI:0000869;polyA RNA;polyA RNA;;;;;;;EFO:0009922;10x 3' v3 sequencing;10x 3' v3 sequencing;;;;;;;;;;;;single cell;poly-dT;;GEM generation and barcoding, reverse-transcription, cDNA generation were done following the manufacturer’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics). Library construction were done following the manufacture’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics).;10x_library_protocol;Chromium 10x single-cell RNA-seq library generation.;;;;;;;;;;first;12.0;16.0;Read 1;;;;;;SRX8419315;SRX8419315;;;;;;;;;;;;;;;;;;SRX8419315;;;;;;;;;;;;;data:3494;DNA sequence;DNA sequence;endo_39_S8_L001_I1_001.fastq.gz;endo_39_S8_L001_R1_001.fastq.gz;endo_39_S8_L001_R2_001.fastq.gz;fastq.gz;SRR11869231;1.0;1.0;SRX8419315;read1;;;;;Cellranger;3.1.0;;EFO:0008637;Illumina NovaSeq 6000;Illumina NovaSeq 6000;;EFO:0008440;tag based single cell RNA sequencing;tag based single cell RNA sequencing;no;;Dual-indexed, single-cell libraries were pooled and sequenced in paired-end reads on Novaseq (Illumina).;GPL24676;Illumina NovaSeq 6000;;;;Endometrial biopsy taken 23 days after the onset of menstrual bleeding.;day23-10x-endometrium_biopsy;;;;;9606.0;;;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;UBERON:0001295;endometrium;endometrium;;;;dissociation_protocol;1;['dissociation_protocol'];enrichment_protocol_1;1;['enrichment_protocol_1']
;;GSM4577310;GSM4577310;day23-10x-endometrium_biopsy-cells;SAMN15049047;;;9606.0;;;;;;;;;;;;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;;;;;collection_protocol;dissociation_protocol;;"The donor is one of a group of healthy and fertile women aged 18-34 years with regular menstrual cycling (3-4 d every 28-30 d), body mass index 19-29 kg m-2 (inclusive), normal karyotype and negative serological tests for human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis. Women with the following conditions were excluded from tissue collection: recent contraception (intrauterine device usage in past 3 months; hormonal contraceptives in past 2 months), uterine pathology (endometriosis, leiomyoma or adenomyosis; bacterial, fungal or viral infection) or polycystic ovary syndrome.";day23-10x;;;;;9606.0;;HsapDv:0000087;human adult stage;human adult stage;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;yes;18-34;UO:0000036;year;year;female;enrichment_protocol_1;14;;;;16.0;0.0;Read 1;;3 prime tag;OBI:0000869;polyA RNA;polyA RNA;;;;;;;EFO:0009922;10x 3' v3 sequencing;10x 3' v3 sequencing;;;;;;;;;;;;single cell;poly-dT;;GEM generation and barcoding, reverse-transcription, cDNA generation were done following the manufacturer’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics). Library construction were done following the manufacture’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics).;10x_library_protocol;Chromium 10x single-cell RNA-seq library generation.;;;;;;;;;;first;12.0;16.0;Read 1;;;;;;SRX8419315;SRX8419315;;;;;;;;;;;;;;;;;;SRX8419315;;;;;;;;;;;;;data:3494;DNA sequence;DNA sequence;endo_39_S8_L002_I1_001.fastq.gz;endo_39_S8_L002_R1_001.fastq.gz;endo_39_S8_L002_R2_001.fastq.gz;fastq.gz;SRR11869232;2.0;2.0;SRX8419315;read1;;;;;Cellranger;3.1.0;;EFO:0008637;Illumina NovaSeq 6000;Illumina NovaSeq 6000;;EFO:0008440;tag based single cell RNA sequencing;tag based single cell RNA sequencing;no;;Dual-indexed, single-cell libraries were pooled and sequenced in paired-end reads on Novaseq (Illumina).;GPL24676;Illumina NovaSeq 6000;;;;Endometrial biopsy taken 23 days after the onset of menstrual bleeding.;day23-10x-endometrium_biopsy;;;;;9606.0;;;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;UBERON:0001295;endometrium;endometrium;;;;dissociation_protocol;1;['dissociation_protocol'];enrichment_protocol_1;1;['enrichment_protocol_1']
;;GSM4577314;GSM4577314;day26-early-secretory-10x-endometrium_biopsy-cells;SAMN15049043;;;9606.0;;;;;;;;;;;;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;;;;;collection_protocol;dissociation_protocol;;"The donor is one of a group of healthy and fertile women aged 18-34 years with regular menstrual cycling (3-4 d every 28-30 d), body mass index 19-29 kg m-2 (inclusive), normal karyotype and negative serological tests for human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis. Women with the following conditions were excluded from tissue collection: recent contraception (intrauterine device usage in past 3 months; hormonal contraceptives in past 2 months), uterine pathology (endometriosis, leiomyoma or adenomyosis; bacterial, fungal or viral infection) or polycystic ovary syndrome.";day26-early-secretory-10x;;;;;9606.0;;HsapDv:0000087;human adult stage;human adult stage;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;yes;18-34;UO:0000036;year;year;female;enrichment_protocol_1;15;;;;16.0;0.0;Read 1;;3 prime tag;OBI:0000869;polyA RNA;polyA RNA;;;;;;;EFO:0009922;10x 3' v3 sequencing;10x 3' v3 sequencing;;;;;;;;;;;;single cell;poly-dT;;GEM generation and barcoding, reverse-transcription, cDNA generation were done following the manufacturer’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics). Library construction were done following the manufacture’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics).;10x_library_protocol;Chromium 10x single-cell RNA-seq library generation.;;;;;;;;;;first;12.0;16.0;Read 1;;;;;;SRX8419319;SRX8419319;;;;;;;;;;;;;;;;;;SRX8419319;;;;;;;;;;;;;data:3494;DNA sequence;DNA sequence;endo_60_S5_L001_I1_001.fastq.gz;endo_60_S5_L001_R1_001.fastq.gz;endo_60_S5_L001_R2_001.fastq.gz;fastq.gz;SRR11869238;1.0;1.0;SRX8419319;read1;;;;;Cellranger;3.1.0;;EFO:0008637;Illumina NovaSeq 6000;Illumina NovaSeq 6000;;EFO:0008440;tag based single cell RNA sequencing;tag based single cell RNA sequencing;no;;Dual-indexed, single-cell libraries were pooled and sequenced in paired-end reads on Novaseq (Illumina).;GPL24676;Illumina NovaSeq 6000;;;;Endometrial biopsy taken 26 days after the onset of menstrual bleeding.;day26-early-secretory-10x-endometrium_biopsy;;;;;9606.0;;;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;UBERON:0001295;endometrium;endometrium;;;;dissociation_protocol;1;['dissociation_protocol'];enrichment_protocol_1;1;['enrichment_protocol_1']
;;GSM4577314;GSM4577314;day26-early-secretory-10x-endometrium_biopsy-cells;SAMN15049043;;;9606.0;;;;;;;;;;;;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;;;;;collection_protocol;dissociation_protocol;;"The donor is one of a group of healthy and fertile women aged 18-34 years with regular menstrual cycling (3-4 d every 28-30 d), body mass index 19-29 kg m-2 (inclusive), normal karyotype and negative serological tests for human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis. Women with the following conditions were excluded from tissue collection: recent contraception (intrauterine device usage in past 3 months; hormonal contraceptives in past 2 months), uterine pathology (endometriosis, leiomyoma or adenomyosis; bacterial, fungal or viral infection) or polycystic ovary syndrome.";day26-early-secretory-10x;;;;;9606.0;;HsapDv:0000087;human adult stage;human adult stage;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;;;;;yes;18-34;UO:0000036;year;year;female;enrichment_protocol_1;16;;;;16.0;0.0;Read 1;;3 prime tag;OBI:0000869;polyA RNA;polyA RNA;;;;;;;EFO:0009922;10x 3' v3 sequencing;10x 3' v3 sequencing;;;;;;;;;;;;single cell;poly-dT;;GEM generation and barcoding, reverse-transcription, cDNA generation were done following the manufacturer’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics). Library construction were done following the manufacture’s protocol (Single cell 3’ reagent kits v3.1, Chromium Next GEM Chip G, 10x Genomics).;10x_library_protocol;Chromium 10x single-cell RNA-seq library generation.;;;;;;;;;;first;12.0;16.0;Read 1;;;;;;SRX8419319;SRX8419319;;;;;;;;;;;;;;;;;;SRX8419319;;;;;;;;;;;;;data:3494;DNA sequence;DNA sequence;endo_60_S5_L002_I1_001.fastq.gz;endo_60_S5_L002_R1_001.fastq.gz;endo_60_S5_L002_R2_001.fastq.gz;fastq.gz;SRR11869239;2.0;2.0;SRX8419319;read1;;;;;Cellranger;3.1.0;;EFO:0008637;Illumina NovaSeq 6000;Illumina NovaSeq 6000;;EFO:0008440;tag based single cell RNA sequencing;tag based single cell RNA sequencing;no;;Dual-indexed, single-cell libraries were pooled and sequenced in paired-end reads on Novaseq (Illumina).;GPL24676;Illumina NovaSeq 6000;;;;Endometrial biopsy taken 26 days after the onset of menstrual bleeding.;day26-early-secretory-10x-endometrium_biopsy;;;;;9606.0;;;PATO:0000461;normal;normal;NCBITaxon:9606;Homo sapiens;Homo sapiens;UBERON:0001295;endometrium;endometrium;;;;dissociation_protocol;1;['dissociation_protocol'];enrichment_protocol_1;1;['enrichment_protocol_1']
